Jefferies Group's position in Boston Scientific is currently worth $32.1 Million. That's 0.45% of their equity portfolio (43rd largest holding). The first Boston Scientific trade was made in Q2 2018. Since then Jefferies Group bought shares five more times and sold shares on five occasions. The stake costed the investor $21.3 Million, netting the investor a gain of 51% so far.
Jefferies Financial Group Inc. boosted its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 124.3% in the second quarter, according to the compa...
With their robustness and growth potential, healthcare stocks are becoming a focal point in portfolios worldwide. Moreover, the U.S. stands out at the forefr...
Any physician that implants a Boston Scientific’s marlex mid-urethral sling is exposed to big legal problems
PARIS, FRANCE and BOSTON, MA / ACCESSWIRE / September 26, 2022 / TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for t...